In addition, our study identified formiminotransferase cyclodeaminase (FTCD) as a classification-specific prognostic gene with anti-tumor effects in HCC, serving as a potential therapeutic target for specific molecular classifications through bioinformatics screening and experimental evidence. This evidence concerns the gene FTCD and hepatocellular carcinoma.